Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

4.2%

1 terminated/withdrawn out of 24 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

46%

11 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

Phase 3
7(35.0%)
N/A
6(30.0%)
Phase 4
4(20.0%)
Phase 2
3(15.0%)
20Total
Phase 3(7)
N/A(6)
Phase 4(4)
Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT07620626Recruiting

Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment

Role: collaborator

NCT07514611Not ApplicableRecruiting

Weight Loss Via Intelligent Guidance in Patients With Coronary Heart Disease and Obesity: a Randomized Clinical Trial

Role: collaborator

NCT06265051Phase 2Completed

Tirofiban After Successful MT Recanalization in AIS

Role: collaborator

NCT07345611Phase 4Not Yet Recruiting

Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis B

Role: collaborator

NCT07345624Phase 4Not Yet Recruiting

Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis B

Role: collaborator

NCT07235345Not ApplicableEnrolling By Invitation

To Investigate the Effect of Pulmonary Surfactant With Different Inspired Oxygen Concentrations on the Clinical Outcomes of Very Preterm Infants Under Non-invasive Assisted Ventilation

Role: collaborator

NCT02737189Not ApplicableCompleted

Basilar Artery Occlusion Chinese Endovascular Trial

Role: collaborator

NCT06349655Completed

The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19

Role: collaborator

NCT05965687Phase 3Recruiting

Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)

Role: collaborator

NCT05965193Phase 3Recruiting

Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke:Longterm Outcome (OPENS-3L)

Role: collaborator

NCT04681651Phase 2Completed

Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)

Role: collaborator

NCT02025036Phase 3Unknown

Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer

Role: collaborator

NCT05282563Not ApplicableUnknown

Clinical Study on the Safety of Double and a Half Layered Esophagojejunal Anastomosis in Curative Gastrectomy

Role: collaborator

NCT02621333Phase 2Terminated

Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma

Role: collaborator

NCT04850950Phase 4Unknown

Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B

Role: collaborator

NCT04775836Unknown

An EHR-based Platform To Facilitate Outcomes and Research Methods in Cerebrovascular Diseases

Role: collaborator

NCT04020536Recruiting

Real World Study of Classic Infectious Disease

Role: collaborator

NCT04286503Phase 4Unknown

The Clinical Study of Carrimycin on Treatment Patients With COVID-19

Role: collaborator

NCT03406832Not ApplicableUnknown

Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI

Role: collaborator

NCT03950518Phase 3Unknown

Novel Treatment of Advanced Hepatocellular Carcinoma

Role: collaborator